We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Snibe Co.,Ltd.

Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe) is a global leader in the IVD field, with 30 years o... read more Featured Products: More products

Download Mobile App




Advanced Electrolyte Analyzer Offers Fully Automatic iCa2+ Analysis

By LabMedica International staff writers
Posted on 31 May 2022

Snibe (Shenzhen, China) has launched the latest Biossays E6 electrolyte analyzer, ushering in a new era of fully automatic iCa2+ analysis. More...

Biossays E6 is a small-size electrolyte analyzer (space occupied <0.23 m2) with a high throughput of 300 tests per hour (60 samples per hour) and five electrodes as per request in any combination: iCa2+, Na+, K+, Cl-, pH. Biossays E6 adopts the automatic puncture sampling method for anaerobic measurement to ensure the stability of ionized calcium levels and the accuracy of measurement. Ionized calcium is physiologically active calcium that can reflect the metabolic state of calcium and can better reflect the patient’s true calcium level.

Samples can be loaded continuously, and 30 samples can be loaded in a single operation. Different negative pressure sampling algorithms ensure accurate and sufficient vacuum sampling. Biossays E6 supports STAT mode and requires 90ul sample of serum, whole blood, plasma or urine. It also offers hedging type full pipettor cleaning to avoid cross-contamination and is connectable to the lab’s Total Laboratory Automation System. Its fully automatic sample loading, puncture sampling, calibration, detection and cleaning improves efficiency and ensures hands-free operation. Its user-friendly design and 12-inch touch screen make it easier to operate the Biossays E6 electrolyte analyzer and visualize data intuitively.

Related Links:
Snibe 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Automated Urinalysis Solution
UN-9000
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Industry

view channel
Image: The partnership aims to broaden access to ultrasensitive blood-based testing for multiple myeloma and other hematologic malignancies (Image credit: 123RF)

Partnership Expands Ultrasensitive Blood-Based Diagnostics for Hematologic Malignancies

Predicta Biosciences (Cambridge, MA, USA) and CIMA LAB Diagnostics at Clínica Universidad de Navarra (Pamplona, Spain) have entered an agreement to provide a joint service that combines CIMA LAB’s flow... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.